Clinical trial
Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir
NCT00031486 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00031486 |
|---|---|
| Title | Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir |
| Official title | A Phase III Double-Blind, Placebo-Controlled Trial of Long Term Therapy of Herpes Simplex Encephalitis (HSE): An Evaluation of Valacyclovir (CASG-204) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Encephalitis |
| Intervention type | Drug |
| Interventions | Valacyclovir, Placebo |
| Enrollment | 91 |
| Start date | Sep 1, 2000 |
| Primary completion | Jun 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Mar 7, 2002 |
| Last update posted | Jun 12, 2012 |
| Countries | Canada, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: